RisperDAL CONSTA 37.5 mg Injection
RxNorm 706827
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 706827 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: RisperDAL CONSTA 37.5 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Risperdal 37.5 mg Injection
(Atom ID: 7746087)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
RisperDAL 37.5 mg Injection
(Atom ID: 7747332)
PSNPrescribable
Prescribable Name (PSN):
RisperDAL CONSTA 37.5 mg Injection
(Atom ID: 7747135)
SBDPrescribable
Semantic Branded Drug (SBD):
Risperidone 37.5 mg Injection [Risperdal]
(Atom ID: 12361781)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
RisperiDONE 37.5 mg Injection [RisperDAL]
(Atom ID: 7747402)
Patient Education
Risperidone Injection
Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.